OHSU to provide new, FDA-approved gene therapy for a form of blindness

Oregon one of four places nationwide currently set to offer treatment for this kind of inherited retinal disease

By Franny White December 26, 2017 Portland, Ore.

Downloads

David Wilson, M.D.

David Wilson, M.D., OHSU Casey Eye Institute director. (OHSU)

Mark Pennesi M.D., Ph.D.

Mark Pennesi, M.D., Ph.D., chief of the ophthalmic genetics division at Casey Eye Institute, OHSU. (OHSU)